Moreover, in a K-RAS mutant lung cancer mouse model, a combination of a MEK inhibitor at doses below the maximum tolerated dose with a PI3K/AKT/mTOR inhibitor was found to suppress the growth of the tumors [38]. This evidence concerns the gene MAP2K7 and lung cancer.